These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 28676011)

  • 21. Gene expression analysis of novel genes in the prefrontal cortex of major depressive disorder subjects.
    Goswami DB; Jernigan CS; Chandran A; Iyo AH; May WL; Austin MC; Stockmeier CA; Karolewicz B
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():126-33. PubMed ID: 23261523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurobiology of Depression: Chronic Stress Alters the Glutamatergic System in the Brain-Focusing on AMPA Receptor.
    Lee MT; Peng WH; Kan HW; Wu CC; Wang DW; Ho YC
    Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune and Neuroendocrine Mechanisms of Stress Vulnerability and Resilience.
    Ménard C; Pfau ML; Hodes GE; Russo SJ
    Neuropsychopharmacology; 2017 Jan; 42(1):62-80. PubMed ID: 27291462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AMPA receptor subunit 1 (GluR-A) knockout mice model the glutamate hypothesis of depression.
    Chourbaji S; Vogt MA; Fumagalli F; Sohr R; Frasca A; Brandwein C; Hörtnagl H; Riva MA; Sprengel R; Gass P
    FASEB J; 2008 Sep; 22(9):3129-34. PubMed ID: 18492725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Update on Glutamatergic System in Suicidal Depression and on the Role of Esketamine.
    De Berardis D; Tomasetti C; Pompili M; Serafini G; Vellante F; Fornaro M; Valchera A; Perna G; Volpe U; Martinotti G; Fraticelli S; Di Giannantonio M; Kim YK; Orsolini L
    Curr Top Med Chem; 2020; 20(7):554-584. PubMed ID: 32003691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amygdala functional connectivity in major depression - disentangling markers of pathology, risk and resilience.
    Wackerhagen C; Veer IM; Erk S; Mohnke S; Lett TA; Wüstenberg T; Romanczuk-Seiferth NY; Schwarz K; Schweiger JI; Tost H; Meyer-Lindenberg A; Heinz A; Walter H
    Psychol Med; 2020 Dec; 50(16):2740-2750. PubMed ID: 31637983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physical Exercise and Neuroinflammation in Major Depressive Disorder.
    Ignácio ZM; da Silva RS; Plissari ME; Quevedo J; Réus GZ
    Mol Neurobiol; 2019 Dec; 56(12):8323-8335. PubMed ID: 31228000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of early-life stress and resilience on patients with major depressive disorder.
    Seok JH; Lee KU; Kim W; Lee SH; Kang EH; Ham BJ; Yang JC; Chae JH
    Yonsei Med J; 2012 Nov; 53(6):1093-8. PubMed ID: 23074107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased Homer1-mGluR5 mediates chronic stress-induced depressive-like behaviors and glutamatergic dysregulation via activation of PERK-eIF2α.
    Li MX; Li Q; Sun XJ; Luo C; Li Y; Wang YN; Chen J; Gong CZ; Li YJ; Shi LP; Zheng YF; Li RC; Huang XL; Xiong QJ; Chen H
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109682. PubMed ID: 31265863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyloid Fibril-Induced Astrocytic Glutamate Transporter Disruption Contributes to Complement C1q-Mediated Microglial Pruning of Glutamatergic Synapses.
    Wu J; Bie B; Foss JF; Naguib M
    Mol Neurobiol; 2020 May; 57(5):2290-2300. PubMed ID: 32008166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P2X7 regenerative-loop potentiation of glutamate synaptic transmission by microglia and astrocytes.
    Bennett MR; Farnell L; Gibson WG
    J Theor Biol; 2009 Nov; 261(1):1-16. PubMed ID: 19643112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bidirectional Homeostatic Regulation of a Depression-Related Brain State by Gamma-Aminobutyric Acidergic Deficits and Ketamine Treatment.
    Ren Z; Pribiag H; Jefferson SJ; Shorey M; Fuchs T; Stellwagen D; Luscher B
    Biol Psychiatry; 2016 Sep; 80(6):457-468. PubMed ID: 27062563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glutamatergic dysregulation in pediatric psychiatric disorders: a systematic review of the magnetic resonance spectroscopy literature.
    Spencer AE; Uchida M; Kenworthy T; Keary CJ; Biederman J
    J Clin Psychiatry; 2014 Nov; 75(11):1226-41. PubMed ID: 25271988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fractalkine receptor deficiency impairs microglial and neuronal responsiveness to chronic stress.
    Milior G; Lecours C; Samson L; Bisht K; Poggini S; Pagani F; Deflorio C; Lauro C; Alboni S; Limatola C; Branchi I; Tremblay ME; Maggi L
    Brain Behav Immun; 2016 Jul; 55():114-125. PubMed ID: 26231972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resilience and Vulnerability to Stress-Induced Anhedonia: Unveiling Brain Gene Expression and Mitochondrial Dynamics in a Mouse Chronic Stress Depression Model.
    Strekalova T; Svirin E; Gorlova A; Sheveleva E; Burova A; Khairetdinova A; Sitdikova K; Zakharova E; Dudchenko AM; Lyundup A; Morozov S
    Biomolecules; 2023 Dec; 13(12):. PubMed ID: 38136653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glutamate and GABA in Microglia-Neuron Cross-Talk in Alzheimer's Disease.
    Czapski GA; Strosznajder JB
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glutamatergic Signaling Drives Ketamine-Mediated Response in Depression: Evidence from Dynamic Causal Modeling.
    Gilbert JR; Yarrington JS; Wills KE; Nugent AC; Zarate CA
    Int J Neuropsychopharmacol; 2018 Aug; 21(8):740-747. PubMed ID: 29668918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status.
    Henter ID; Park LT; Zarate CA
    CNS Drugs; 2021 May; 35(5):527-543. PubMed ID: 33904154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The reduction of microglial efferocytosis is concomitant with depressive-like behavior in CUMS-treated mice.
    Xiao Y; Chen Y; Huang S; He H; Hu N; Lin S; You Z
    J Affect Disord; 2024 May; 352():76-86. PubMed ID: 38360363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain-wide changes in excitation-inhibition balance of major depressive disorder: a systematic review of topographic patterns of GABA- and glutamatergic alterations.
    Hu YT; Tan ZL; Hirjak D; Northoff G
    Mol Psychiatry; 2023 Aug; 28(8):3257-3266. PubMed ID: 37495889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.